Keywords: Allergan, First-quarter 2012 financial results

Allergan's1 st-qtr profits leap 45%

Article | 03 May 2012

USA-based Allergan (NYSE: AGN) reported financial results for the first quarter of 2012, with diluted earnings rocketing 45% to $230.3 million, or $0.74 per ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in